Mutations in the neuronal syntaxin gene
unc-64 profoundly alter the volatile anesthetic (VA) sensitivity of C. elegans. Two hypomorphic
unc-64 alleles confer hypersensitivity to the VAs isoflurane and halothane, but a third
unc-64 hypomorph,
md130, which produces a truncated syntaxin product, is VA resistant. The difference between the isoflurane EC50s of the hypersensitive and resistant alleles is over 30-fold; this is by far the biggest allelic variation in VA sensitivity thusfar seen in any animal. Given that these allelic differences cannot be explained by indirect effects on synaptic transmission and can be rescued and knocked-in, we hypothesized that syntaxin or a syntaxin-binding protein binds VAs and that the truncated
md130 product somehow interferes with that binding. We have looked for isoflurane binding to syntaxin and to two syntaxin-binding proteins, VAMP and SNAP-25, which form a ternary complex with syntaxin to mediate synaptic vesicle fusion. Recombinant expression proteins (C. elegans syntaxin and VAMP - coded for by
snb-1, and rat SNAP-25 - plasmids all kindly provided by M. Nonet) without their transmembrane domains or lipid modifications were used. We used 19F-NMR to measure binding of isoflurane to the purified proteins. The transverse relaxation time (T2) of a nucleus is known to decrease when its Brownian motion decreases; thus, binding of small molecules (eg. isoflurane) to larger ones (eg., a protein) shortens T2s. We found that the T2 of the CF3-moiety of isoflurane was significantly shorter in solutions containing SNAP-25 than in buffer alone and was protein and isoflurane concentration dependent, changing over the in vivo relevant isoflurane concentration range. Recombinant syntaxin had no effect on the T2. We are currently gathering data for VAMP and the ternary complex. Thus, our data show that SNAP-25 but not syntaxin binds isoflurane at relevant concentrations; SNAP-25 is the first neuronal protein shown to bind VAs. Given our genetic data in C. elegans and electrophysiologic data in vertebrates showing that neurotransmitter release is reduced by VAs, we think that SNAP-25 may be a VA target that mediates some aspects of general anesthesia.